New Sanofi-Aventis Breast Cancer Drug Shows Little Benefit
Clinical trials of a new Sanofi-Aventis drug, iniparib, showed dismal results at treating and improving survival rates of patients with breast cancer.
Clinical trials of a new Sanofi-Aventis drug, iniparib, showed dismal results at treating and improving survival rates of patients with breast cancer.
When analyzing the diseased cells under a microscope, there is a protein that binds two separate diseases together.
Federal health officials explain that certain types of breast implants may increase risks of having anaplastic large cell lymphoma (ALCL), a very rare cancer.
The United States Preventive Services Task Force recommendation may have overlooked evidence that could save lives.
Researchers found that women who are regular smokers, specifically prior to menopause, notice much higher risks of breast cancer when compared to women who do not smoke.
New research has found that a long-known drug to help treat breast cancer may also be used to reduce death risks from lung cancer as well.
German cancer research scientists explain that upwards of 30 percent of breast cancer cases can be completely prevented if a woman takes the necessary precautions.
An evergreen tree extract, a very powerful drug, might assist in decreasing the mortality rate of breast cancer.
Scientists have been studying the ability to use autologous fat stem cells in breast augmentation for the reconstruction of a breast after cancer surgery.
Black women may be at a higher risk of developing aggressive breast cancer due to having less vitamin D in their bodies than white women.